Fayez Raza is a Cardiology physician affiliated with Baylor University Medical Center. OpenAlex indexes 13 publications with 225 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3500 Gaston Ave
Dallas, TX 752462017
Telephone
214-820-0000Provider last certified this registry record 11 Apr 2022.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20257 payments
- Cleerly, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89.4%Beta blocker23.5%Metoprolol Succinate46%Carvedilol34%Nebivolol Hcl11%Metoprolol Tartrate8%Bisoprolol Fumarate2%Part D<11 patientsAdenosine Receptor Agonist18.8%Regadenoson100%Part B, office-administered≥160 patients+ 13 more classes in this area
Blood & clotting
9.1%Factor Xa inhibitor7.3%Eliquis74%Xarelto26%Part D≥46 patientsP2Y12 inhibitor1.4%Clopidogrel100%Part D≥15 patients+ 1 more class in this area
Metabolism & gastrointestinal
1%SGLT2 inhibitor1%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation
Journal of the American Heart Association
2018 - Relation of Vasoplegia in the Absence of Primary Graft Dysfunction to Mortality Following Cardiac Transplantation
The American Journal of Cardiology
2018 - Usefulness of a left ventricular assist device in patients with left ventricular noncompaction
Baylor University Medical Center Proceedings
2018 - Use of a Mitraclip for Severe Mitral Regurgitation in a Cardiac Transplant Patient
Baylor University Medical Center Proceedings
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Grayburn, MD
Baylor University Medical Center
Stuart Spechler, MD
Baylor University Medical Center
Brooks Cash, MD
Baylor University Medical Center
Robert Perrillo, MD
Baylor University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”